News Feed Item

Caribbean International Holdings (CIHN) Announces Change in Control; Seasoned Veteran in Stem Cell Industry Appointed as New CEO

Mark Farber MD, PhD, MS Received Degrees From Brown University and SUNY; During His Time at Harvard Medical School He Developed Bioreactor Designs for Stem Cell Based Tissue Engineered Heart Valves

SARASOTA, FL--(Marketwired - September 04, 2014) - Caribbean International Holdings (PINKSHEETS: CIHN) through its subsidiary, Regenerative BioScience, Inc. ("RBS"), announced today that on August 27, 2014, a private investment group, J3 Financial, has acquired a controlling interest in the Company. Former CEO and former controlling shareholder, Steven Swank has resigned as of that same date; and effective as of August 28, 2014, the Company has appointed Mark Farber MD, PhD, MS as the new CEO of CIHN.

A spokesperson for J3 stated that: "We had been tracking CIHN for some time and found its business model very attractive. We feel that this is a company that is ready to emerge and being able to acquire the talents and services of someone like Dr. Farber, will help us establish a sound foundation for future growth. We feel very lucky to have him onboard."

The Company also said that it intends to identify, recruit and hire additional industry professionals within the emerging stem cell industry as it builds the infrastructure to support a solid but steady growth. It will also be adding administrative and other veteran executives in key positions.

The Company spokesperson also said that the Company feels it is important in today's market to keep its shareholders fully abreast of ongoing events and or news and it plans on keeping the market up to date in order to remain fully transparent with the Company's current and/or potential future shareholders and the market at large. In that light, management of the Company will shortly be releasing a Shareholder Update and other pertinent information as it becomes available.

Below is a brief background and bio on the new CEO of CIHN, Mark Farber, MD, PhD, MS.

Dr. Mark Farber received his undergraduate degree in Chemical Engineering from Brown University in Providence, RI in 2001, followed by a Masters in Science in Engineering from Brown University in 2003. He received his MD/PhD combined degree from SUNY Downstate Medical Center in Brooklyn, NY in 2013. His PhD project titled "Simultaneous functional diffuse optical tomography and EEG in freely moving rats" involved developing an emerging non-invasive optical imaging technology to investigate brain blood flow in anesthetized, freely foraging, and sleeping rats. 

During the development of the diffuse optical tomography optical imager, Dr. Farber's research generated over $7 million in grants, including $130,000 from the competitive NIH Ruth Kirschstein National Research Service Award for MD/PhD students from the NIH/NINDS. The technology behind his PhD project for rat brain imaging was sold for over $750,000, and with the assistance of Dr. Farber his technology has been adapted for use in macaque research, clinical research, and the development of brain-machine interfaces.

Prior to completing his education in medicine and engineering, Dr. Farber spent three years working in developing stem cell bioreactors for use in research and tissue engineering. After completing his MS in Engineering, Dr. Farber briefly worked at ViaCell Inc. where he developed bioreactors to maximize stem cell yields from umbilical cord blood cultures. He then moved on to Harvard Medical School, where he worked in the Cardiovascular Pathology department and participated in research projects involving atherosclerosis, heart valve disease, embryology, and tissue engineering. During this time he initiated investigations into novel computerized methods of tissue collagen detection and quantification and developed bioreactor designs for stem cell based tissue engineered heart valves. 

Dr. Farber has also worked at top immunology, cancer, and chemical engineering labs in Brown University and National Institutes of Health during his undergraduate education. He was also a lecturer in anatomy and biostatistics at SUNY Downstate. Dr. Farber has over 17 years experience in laboratory-based science and engineering research.

About The Company:

Caribbean International Holdings, Inc. is a holding company for Regenerative Bio Science, Inc. ("RBSI"). The Company subsidiary RBSI is focused on helping individuals protect and ensure their future quality of life through Adult Stem Cell Incubation and the practice of regenerative medicine in the United States and the Dominican Republic. RBSI's mission is not only to allow patients to store their Stem Cells for future use, but also perform patient funded stem cell therapies from sports injuries to degenerative diseases such as MS, Arthritis, Degenerative Heart Diseases, Diabetes and a host of experimental therapies in the brain trauma disease sector including CTE. The goal is to become a global leader in establishing protocols that can be patented and utilized to heal patients around the world. 

Adult stem cells work as the repairmen of the body by replenishing and regenerating damaged tissues and cells. Certain conditions have shown marked improvement when treated with adult stem cells taken from the patient's own body. Regenerative BioScience is a revolution in healthcare using a patient's own adult stem cells.

For more information go to: http://www.regenerativebioscience.com/index.html.

Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available on at http://www.sec.gov.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
The standardization of container runtimes and images has sparked the creation of an almost overwhelming number of new open source projects that build on and otherwise work with these specifications. Of course, there's Kubernetes, which orchestrates and manages collections of containers. It was one of the first and best-known examples of projects that make containers truly useful for production use. However, more recently, the container ecosystem has truly exploded. A service mesh like Istio addr...
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory? In her Day 2 Keynote at @DevOpsSummit at 21st Cloud Expo, Aruna Ravichandran, VP, DevOps Solutions Marketing, CA Technologies, was jo...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
As IoT continues to increase momentum, so does the associated risk. Secure Device Lifecycle Management (DLM) is ranked as one of the most important technology areas of IoT. Driving this trend is the realization that secure support for IoT devices provides companies the ability to deliver high-quality, reliable, secure offerings faster, create new revenue streams, and reduce support costs, all while building a competitive advantage in their markets. In this session, we will use customer use cases...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H...
The IoT Will Grow: In what might be the most obvious prediction of the decade, the IoT will continue to expand next year, with more and more devices coming online every single day. What isn’t so obvious about this prediction: where that growth will occur. The retail, healthcare, and industrial/supply chain industries will likely see the greatest growth. Forrester Research has predicted the IoT will become “the backbone” of customer value as it continues to grow. It is no surprise that retail is ...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of bus...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
DXWorldEXPO LLC announced today that "Miami Blockchain Event by FinTechEXPO" has announced that its Call for Papers is now open. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Financial enterprises in New York City, London, Singapore, and other world financial capitals are embracing a new generation of smart, automated FinTech that eliminates many cumbersome, slow, and expe...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...